NO20005400L - Kinoloner anvendt som MRS-inhibitorer og baktericider - Google Patents
Kinoloner anvendt som MRS-inhibitorer og baktericiderInfo
- Publication number
- NO20005400L NO20005400L NO20005400A NO20005400A NO20005400L NO 20005400 L NO20005400 L NO 20005400L NO 20005400 A NO20005400 A NO 20005400A NO 20005400 A NO20005400 A NO 20005400A NO 20005400 L NO20005400 L NO 20005400L
- Authority
- NO
- Norway
- Prior art keywords
- bactericides
- inhibitors
- mrs
- quinolones
- quinolones used
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809050.9A GB9809050D0 (en) | 1998-04-29 | 1998-04-29 | Novel compounds |
| GBGB9824571.5A GB9824571D0 (en) | 1998-11-09 | 1998-11-09 | Novel compounds |
| PCT/EP1999/002648 WO1999055677A1 (en) | 1998-04-29 | 1999-04-15 | Quinolones used as mrs inhibitors and bactericides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005400D0 NO20005400D0 (no) | 2000-10-26 |
| NO20005400L true NO20005400L (no) | 2000-10-26 |
Family
ID=26313554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005400A NO20005400L (no) | 1998-04-29 | 2000-10-26 | Kinoloner anvendt som MRS-inhibitorer og baktericider |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6320051B1 (es) |
| EP (1) | EP1084110A1 (es) |
| JP (1) | JP2002513005A (es) |
| KR (1) | KR20010043131A (es) |
| CN (1) | CN1307565A (es) |
| AR (1) | AR018199A1 (es) |
| AU (1) | AU3523599A (es) |
| BR (1) | BR9909994A (es) |
| CA (1) | CA2330564A1 (es) |
| CO (1) | CO5080763A1 (es) |
| HU (1) | HUP0103093A3 (es) |
| IL (1) | IL138906A0 (es) |
| NO (1) | NO20005400L (es) |
| PL (1) | PL343680A1 (es) |
| TR (1) | TR200003170T2 (es) |
| WO (1) | WO1999055677A1 (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040014121A1 (en) * | 1996-04-18 | 2004-01-22 | Smithkline Beecham Corporation | Novel compounds |
| GB9822241D0 (en) * | 1998-10-12 | 1998-12-09 | Smithkline Beecham Plc | Novel compounds |
| GB9827467D0 (en) * | 1998-12-15 | 1999-02-10 | Zeneca Ltd | Chemical compounds |
| CA2372079A1 (en) * | 1999-05-05 | 2000-11-09 | Aaron H. Leeman | Novel catechols as antimicrobial agents |
| EP1466603A3 (en) * | 1999-05-05 | 2004-10-20 | Merck & Co., Inc. | Novel catechols as antimicrobial agents |
| GB9911594D0 (en) * | 1999-05-19 | 1999-07-21 | Smithkline Beecham Plc | Novel compounds |
| AU5213300A (en) * | 1999-05-19 | 2000-12-12 | Smithkline Beecham Plc | 2-nh-pyridones and pyrimidones as mrs inhibitors |
| WO2002047687A1 (en) * | 2000-12-11 | 2002-06-20 | Smithkline Beecham Corporation | Urotensin-ii receptor antagonists |
| US20040053963A1 (en) * | 2000-12-11 | 2004-03-18 | Dashyant Dhanak | Urotensin-II receptor antagonists |
| EP1359915A4 (en) * | 2001-01-26 | 2004-07-21 | Smithkline Beecham | UROTENSIN-II RECEPTOR ANTAGONISTS |
| SE0202134D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| MXPA05006567A (es) | 2002-12-20 | 2005-08-16 | Glaxo Group Ltd | Derivados de benzazepina para el tratamiento de trastornos neurologicos. |
| CA2517523A1 (en) * | 2003-03-03 | 2004-09-16 | Replidyne, Inc. | Substituted thiophenes with antibacterial activity |
| GB0304809D0 (en) * | 2003-03-03 | 2003-04-09 | Glaxo Group Ltd | Novel compounds |
| WO2005009336A2 (en) * | 2003-05-01 | 2005-02-03 | Replidyne, Inc. | Antibacterial methods and compositions |
| EP1706384A1 (en) * | 2004-01-07 | 2006-10-04 | AstraZeneca AB | Therapeutic agents i |
| JO3077B1 (ar) * | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
| FR2902100A1 (fr) * | 2006-06-13 | 2007-12-14 | Sanofi Aventis Sa | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
| US7994192B2 (en) | 2006-09-26 | 2011-08-09 | Crestone, Inc. | Substituted thienopyridone compounds with antibacterial activity |
| ES2429289T3 (es) * | 2006-09-26 | 2013-11-14 | Crestone, Inc. | Compuestos enantioméricos con actividad antibacteriana |
| US8697720B2 (en) | 2006-09-26 | 2014-04-15 | Crestone, Inc. | Substituted phenylether-thienopyridone compounds with antibacterial activity |
| WO2008039639A2 (en) * | 2006-09-26 | 2008-04-03 | Crestone, Inc. | Substituted thienopyridone compounds with antibacterial activity |
| US8658670B2 (en) | 2006-09-26 | 2014-02-25 | Crestone, Inc. | Methods and compounds for treatment of clostridium based infection |
| US7973050B2 (en) | 2006-09-26 | 2011-07-05 | Crestone, Inc. | Enantiomeric compounds with antibacterial activity |
| CN104546857B (zh) * | 2013-10-18 | 2017-01-04 | 北京北科德源生物医药科技有限公司 | 化合物naphthoylenequinazolone的抗菌用途 |
| JP7344125B2 (ja) * | 2017-03-30 | 2023-09-13 | エフ. ホフマン-ラ ロシュ アーゲー | 細菌感染の治療及び予防のための新規ピリド[2,3-b]インドール化合物 |
| CN113264878B (zh) * | 2019-11-11 | 2022-05-27 | 山东畜牧兽医职业学院 | 一种用于畜牧业治疗耐药性微生物菌的化合物的制备方法 |
| JP7747664B2 (ja) * | 2020-05-20 | 2025-10-01 | エフ. ホフマン-ラ ロシュ アーゲー | 質量分析のためのベンジルピリジニウム試薬 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4005205A (en) * | 1974-04-24 | 1977-01-25 | Smith Kline & French Laboratories Limited | Compositions and methods for inhibiting H2 histamine receptors |
| GB8332091D0 (en) * | 1983-12-01 | 1984-01-11 | Smith Kline French Lab | Chemical compounds |
| KR950005301B1 (ko) * | 1990-09-04 | 1995-05-23 | 주식회사대웅제약 | 신규한 퀴놀론 카르복실산 유도체 |
| KR960007566A (ko) * | 1994-08-19 | 1996-03-22 | 김정규 | 신규한 퀴놀릴아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도 |
-
1999
- 1999-04-15 BR BR9909994-2A patent/BR9909994A/pt not_active Application Discontinuation
- 1999-04-15 PL PL99343680A patent/PL343680A1/xx unknown
- 1999-04-15 US US09/674,102 patent/US6320051B1/en not_active Expired - Fee Related
- 1999-04-15 IL IL13890699A patent/IL138906A0/xx unknown
- 1999-04-15 HU HU0103093A patent/HUP0103093A3/hu unknown
- 1999-04-15 EP EP99916927A patent/EP1084110A1/en not_active Withdrawn
- 1999-04-15 TR TR2000/03170T patent/TR200003170T2/xx unknown
- 1999-04-15 KR KR1020007012024A patent/KR20010043131A/ko not_active Withdrawn
- 1999-04-15 JP JP2000545837A patent/JP2002513005A/ja active Pending
- 1999-04-15 WO PCT/EP1999/002648 patent/WO1999055677A1/en not_active Ceased
- 1999-04-15 AU AU35235/99A patent/AU3523599A/en not_active Abandoned
- 1999-04-15 CA CA002330564A patent/CA2330564A1/en not_active Abandoned
- 1999-04-15 CN CN99807809A patent/CN1307565A/zh active Pending
- 1999-04-27 AR ARP990101937A patent/AR018199A1/es unknown
- 1999-04-29 CO CO99025654A patent/CO5080763A1/es unknown
-
2000
- 2000-10-26 NO NO20005400A patent/NO20005400L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6320051B1 (en) | 2001-11-20 |
| CN1307565A (zh) | 2001-08-08 |
| KR20010043131A (ko) | 2001-05-25 |
| TR200003170T2 (tr) | 2001-01-22 |
| CO5080763A1 (es) | 2001-09-25 |
| AU3523599A (en) | 1999-11-16 |
| NO20005400D0 (no) | 2000-10-26 |
| HUP0103093A3 (en) | 2002-03-28 |
| PL343680A1 (en) | 2001-08-27 |
| WO1999055677A1 (en) | 1999-11-04 |
| EP1084110A1 (en) | 2001-03-21 |
| IL138906A0 (en) | 2001-11-25 |
| BR9909994A (pt) | 2000-12-26 |
| JP2002513005A (ja) | 2002-05-08 |
| HUP0103093A2 (hu) | 2002-02-28 |
| CA2330564A1 (en) | 1999-11-04 |
| AR018199A1 (es) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005400L (no) | Kinoloner anvendt som MRS-inhibitorer og baktericider | |
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| ATE433963T1 (de) | Fab-i inhibitoren | |
| HK1049656A1 (zh) | Fab i抑制剂 | |
| AU6339599A (en) | Quinoline derivatives and their use as antibacterial agents | |
| AU5986200A (en) | Compounds | |
| TR200000059T2 (tr) | Piridin türevleri | |
| MY138797A (en) | Bacterial gyrase inhibitors and uses thereof | |
| DE60112055D1 (de) | Inhibitoren von gamma-secretase | |
| TR200103216T2 (tr) | Pirimidinon bileşimleri | |
| CY1112442T1 (el) | Παραγωγα πυριδινονης για θεραπεια αθηροσκληρωσης | |
| NO996269L (no) | Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| PL333429A1 (en) | Benzonaphtyridines useful in particular in treating bronchial diseases | |
| SE9803518D0 (sv) | Novel compounds | |
| DE69913712T2 (de) | Inhibitoren der bakteriellen nad synthetase | |
| TR200002605T2 (tr) | Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri | |
| MXPA04004372A (es) | Derivados heterociclicos de glicinamida y su uso medico. | |
| DK0920426T3 (da) | Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning | |
| DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
| TR200002248T2 (tr) | Yeni dihidroksiheksanoik asit türevleri | |
| AP2000001761A0 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. | |
| DK0801655T3 (da) | Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika | |
| DK0808326T3 (da) | Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika | |
| ATE287403T1 (de) | 6-phenylbenzonaphthyidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |